Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Neogen expands its global presence with new disinfectant in Great Britain

Published 11/04/2024, 15:18
Updated 11/04/2024, 15:18

GREATER MANCHESTER, England - Neogen (NASDAQ:NEOG) Corporation (NASDAQ: NEOG) has introduced a new disinfectant, Neogen Farm Fluid MAX, to the Great Britain market, with plans to expand its availability across Europe. The product, part of the company's pathogen control line, is designed to combat protozoa in farm conditions, specifically targeting the coccidiosis-causing oocysts.

Neogen Farm Fluid MAX is an extension of the existing Farm Fluid product range and is engineered to work within Neogen's Pathogen Programme. It has been tested against various strains of Eimeria oocysts, including those responsible for coccidiosis in poultry, with results showing the capability to inactivate both sporulated and non-sporulated forms at a 2% dilution rate.

Andy Hughes, Senior Director of Animal Safety for Neogen in the EMEA region, emphasized the product's effectiveness in difficult farm environments, citing its formulation with chlorocresol (CMK), additional biocides, solvents, and surfactants. The product is intended for use in a variety of settings, including animal housing and sanitation points like wheel and boot dips, and is noted for its stability when exposed to direct sunlight.

Neogen recommends using Farm Fluid MAX on clean, dry surfaces for best results, and as part of a comprehensive pathogen control regimen. This includes a three-step process beginning with cleaning surfaces with Farm-Foam EVO, followed by an initial application of Neogen Viroxide Super disinfectant, and concluding with Farm Fluid MAX.

The announcement of Neogen Farm Fluid MAX's launch is based on a press release statement from the company.

InvestingPro Insights

As Neogen Corporation (NASDAQ: NEOG) makes strides in expanding its product offerings in the Great Britain market, the company's financial health and stock performance provide an interesting backdrop to these developments. Here's a glimpse into Neogen's financial landscape using real-time data and insights from InvestingPro:

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Data shows that Neogen's market capitalization stands at $2.71 billion, reflecting the scale of the company in the competitive landscape. Despite facing challenges, the company's revenue growth over the last twelve months as of Q2 2024 has been impressive at 45.66%, indicating a robust expansion in its business operations. However, it's important to note that Neogen's P/E Ratio (Adjusted) is relatively high at 121.99, which may suggest that the stock is trading at a premium compared to earnings.

From the InvestingPro Tips, two key points stand out. Firstly, Neogen is expected to see net income growth this year, which is a positive sign for potential investors looking for companies with an upward trajectory in profitability. Secondly, the company's liquid assets exceed its short-term obligations, providing it with a cushion to manage its short-term liabilities and invest in growth opportunities like the launch of Neogen Farm Fluid MAX.

Additionally, it is worth mentioning that Neogen is trading near its 52-week low, which could present a potential entry point for investors who believe in the company's long-term value proposition and are looking for a moment to invest.

For readers interested in a deeper analysis, there are more InvestingPro Tips available, which can be found by visiting https://www.investing.com/pro/NEOG. To enhance your experience, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. There are 7 additional InvestingPro Tips listed for Neogen, providing a comprehensive view of the company's financial health and market position.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.